The management of inhibitors in haemophilia A: introduction and systematic review of current practice.
about
Treatment of hemophilia: a review of current advances and ongoing issuesCosts and utilization of treatment in patients with hemophilia.Italian guidelines for the diagnosis and treatment of patients with haemophilia and inhibitors.Recombinant activated factor VII for haemophilia patients with inhibitors undergoing orthopaedic surgery: a review of the literature.Quantitation of anti-factor VIII antibodies in human plasma.Risk factors for high-titer inhibitor development in children with hemophilia A: results of a cohort study.Joint protection in haemophilia.Mortality and causes of death in patients with hemophilia, 1992-2001: a prospective cohort study.Factor VIII inhibitor and source of replacement therapy.Experience of immune tolerance in a carrier of severe haemophilia A with inhibitor development post-surgery.On-demand treatment of bleeds in haemophilia patients with inhibitors: strategies for securing and maintaining predictable efficacy with recombinant activated factor VII.Immune tolerance induction therapy for patients with hemophilia A and FVIII inhibitors particularly using low-dose regimens.Can B-domain deletion alter the immunogenicity of recombinant factor VIII? A meta-analysis of prospective clinical studies.A case of three-year-old boy with severe haemophilia A on prophylaxis identified with a chronic subdural haematoma 2 years after the first episode of acute subdural bleeding.Acquired hemophilia a: from diagnosis to treatment: a case report of an 88-year-old woman.Impact of HLA alleles and cytokine polymorphisms on inhibitors development in children with severe haemophilia A.Health-related quality of life in patients with haemophilia and inhibitors on prophylaxis with anti-inhibitor complex concentrate: results from the Pro-FEIBA study.
P2860
Q35683781-4AEB9148-5B07-4C72-91A2-D49F3F11932AQ35821757-CF9D597E-05C2-4A6E-977E-824C09095BA9Q36291064-C28536B7-FEFD-4CD9-B21D-09FC1530BAD1Q37032862-73925C81-DD34-4831-880F-EF840E3394F3Q37129689-C0146105-695D-44FB-BF9E-F78E77A1AD42Q37253340-61083EFC-11BC-4942-BCEC-DD2785ABE6B9Q37912258-AB932B15-7B42-4141-80E3-4A978EBBBCDAQ38469705-BD2F8A77-DB81-4B1D-B377-91BEC8E63EB2Q43056247-7C890286-745D-4A71-979B-06F31EE40DDDQ45866428-46578162-3FD7-4E95-8623-D50CB6D3960AQ45871901-0AD080A2-D956-48BF-B6E4-94597F4FE488Q45872129-9AD875CA-1801-426D-B115-B9B05B004433Q45872547-9E1D386B-43D9-447A-AE20-661108D4A151Q45873050-7034D090-60C8-48C1-A139-2848D9A210EEQ45886656-6FE4FA75-48F6-40A7-AE01-776298A21030Q45886958-19B67049-A7FA-41CE-B950-086B9C00DD4CQ45887994-1D5DC964-54CA-44F0-9C52-556FC2FC14CA
P2860
The management of inhibitors in haemophilia A: introduction and systematic review of current practice.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
The management of inhibitors i ...... ic review of current practice.
@ast
The management of inhibitors i ...... ic review of current practice.
@en
type
label
The management of inhibitors i ...... ic review of current practice.
@ast
The management of inhibitors i ...... ic review of current practice.
@en
prefLabel
The management of inhibitors i ...... ic review of current practice.
@ast
The management of inhibitors i ...... ic review of current practice.
@en
P2093
P2860
P1433
P1476
The management of inhibitors i ...... ic review of current practice.
@en
P2093
P2860
P304
P356
10.1046/J.1365-2516.2003.00779.X
P577
2003-07-01T00:00:00Z